The market opened in green on August 24, 2020, overall volumes in futures & options currently stand at 1,25,46,616 crore contracts with a turnover of Rs. 8,85,496.25 crore.

Consolidated profit stood at Rs 824.08 crore for Q1FY21. It grew by 35.3 per cent as compared to Rs 609.1 crore that it had reported in Q1FY20.

The market opened in green on August 25, 2020.

It pointed out that pharma companies cumulatively witnessed their pre-tax margins rise by 306 bps on an annualised basis and 551 bps sequentially in Q1 due to the strong revenue growth in the active pharmaceutical ingredient (API) business and lower operating expenses.

The consolidated net sales reported in Q1FY21 came in at Rs 1,022.30 crore, which declined by 42.34 per cent YoY from Rs 1,773.04 crore in Q1FY20.

Lupin Limited has informed the bourses that it has received United States Food and Drug Administration (USFDA) approval for its Albuterol Sulfate Inhalation Aerosol, 90 mcg (base)/actuation. It is a generic version of ProAir HFA.

This move will align the company’s operations as well as capital structure. It will also help in streamlining its financial obligations and will significantly improve credit metrics.

The consolidated net sales reported in Q1FY21 came in at Rs 106.51 crore, which declined by 53.61 per cent YoY from Rs 229.59 crore in Q1FY20. 

Talking about the levels of Nifty, 11,530-11,600 seems to be the next hurdle for the index. On the downside, immediate support is seen around opening the upside gap area (11,412-11,371). Stocks in news: Axis Bank Ltd, Prince Pipes and Fittings Ltd, Indian Bank, Multi Commodity Exchange of India Ltd, Wipro Ltd, Karur Vysya Bank Ltd.

The month of August saw Sensex gain by almost 5 per cent. The bulls clearly have the momentum with them even as there are as many as 350 stocks that are constituents of BSE 500 that outperformed BSE 500 index in August.